Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: New Pacer--ORDER DENYING BARCO’S ADMINISTRATIVE MOTION

<I also read some of the postings r/t DL's suits on his other patents--it appears to me that he is trying to rush filings BEFORE the new patent laws go into effect.>

That statement leads one to believe that there is something in the new law that would impact on how the USPTO will treat the potential reexaminations of those other patents. Hence Leckrone is trying to file before they take effect.

I am not aware of any portion of the new rules that would impact on the reexamination process of those patents. Would appreciate more info from you or anyone, as I'm not totally versed in the new patent law.

Opty

Share
New Message
Please login to post a reply